Sort by
Refine Your Search
-
research programme at Oxford. Candidates should hold a PhD in biomedical engineering, computer science, medical physics, statistics, or a related field. A strong track record of first-/senior or co-author
-
good understanding of the relevant basic theory, skills in data analysis and numerical modelling, and a strong research track record. Please direct enquiries about the role to: Only applications received
-
, publication track record, and ability to contribute to the project. What We Offer As an employer, we genuinely care about our employees’ wellbeing and this is reflected in the range of benefits that we offer
-
the CYCLONE team, whilst managing and prioritising elements of an ambitious list of interesting and impactful objectives. This post offers an outstanding opportunity to advance the Research Associate’s
-
managing and prioritising elements of an ambitious list of exciting and impactful objectives. This post offers an outstanding opportunity to advance the Research Associate’s career in the area of attribution
-
a track record of peer-reviewed publications are essential. This 24 month position is available from 1st October 2025 or shortly thereafter. Group website with research details and publications: https
-
activities. You will have excellent communication skills including a track record of contributing to publications and presentations and an ability to contribute ideas for new research projects. Experience
-
new antibiotics and explore new potential antimicrobial agents. We have a world-class track record of success and a reputation for a can-do attitude to tackling challenging goals. At the heart of our
-
learning, informatics, AI, or a closely related field. You will have an excellent academic track record in topics relevant to manipulation and locomotion; path and motion planning, whole-body control, multi
-
of the Barron Group, including those conducting research in humans, including patient populations. The post holder will be part of the Barron Group based at the MRC BNDU and OxCIN. The Group has a strong track